Clinical Next Generation Sequencing (NGS) - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2759622
- Published On: Oct, 2024
- Category : Medical Devices
- Pages : 155
-
According to latest Research, the global market for Clinical Next Generation Sequencing (NGS) should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Clinical Next Generation Sequencing (NGS) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Clinical Next Generation Sequencing (NGS) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Diagnostics grew percent to account for percent of the total market sales, and Drug Discovery & Designing grew percent.
This report studies and analyses global Clinical Next Generation Sequencing (NGS) status and future trends, to help determine the Clinical Next Generation Sequencing (NGS) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Clinical Next Generation Sequencing (NGS), and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Clinical Next Generation Sequencing (NGS) market size, history data 2019-2024, and forecast data 2024-2029, (US$ million)
(2) Global Clinical Next Generation Sequencing (NGS) by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Clinical Next Generation Sequencing (NGS) by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Clinical Next Generation Sequencing (NGS) key consuming regions, consumption value and demand structure
(5) Clinical Next Generation Sequencing (NGS) industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Agilent Technologies
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI Group
Qiagen
Roche Diagnostics
Bio-Rad
Congenica
Theragen Etex
PerkinElmer
Partek
Oxford Nanopore Technologies
Pacific Biosciences of California
Golden Helix
BioDatomics
PierianDx
DNAStar
Market segment by Type, covers
Sequencing by Synthesis (SBS)
Nanopore Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Others
Market segment by Application, can be divided into
Diagnostics
Drug Discovery & Designing
Medical Research
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Clinical Next Generation Sequencing (NGS) product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Clinical Next Generation Sequencing (NGS) market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Clinical Next Generation Sequencing (NGS) market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Clinical Next Generation Sequencing (NGS) industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Clinical Next Generation Sequencing (NGS) Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Clinical Next Generation Sequencing (NGS) Definition
1.2 Global Clinical Next Generation Sequencing (NGS) Market Size and Forecast
1.3 China Clinical Next Generation Sequencing (NGS) Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Clinical Next Generation Sequencing (NGS) Market Size: China VS Global Growth Rate, 2019-2030
1.6 Clinical Next Generation Sequencing (NGS) Market Dynamics
1.6.1 Clinical Next Generation Sequencing (NGS) Market Drivers
1.6.2 Clinical Next Generation Sequencing (NGS) Market Restraints
1.6.3 Clinical Next Generation Sequencing (NGS) Industry Trends
1.6.4 Clinical Next Generation Sequencing (NGS) Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Clinical Next Generation Sequencing (NGS), Global Market Share by Company, 2019-2024
2.2 Global Clinical Next Generation Sequencing (NGS) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Clinical Next Generation Sequencing (NGS) Concentration Ratio
2.4 Global Clinical Next Generation Sequencing (NGS) Mergers & Acquisitions, Expansion Plans
2.5 Global Clinical Next Generation Sequencing (NGS) Major Companies Product Type
2.6 Head Office and Clinical Next Generation Sequencing (NGS) Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Clinical Next Generation Sequencing (NGS), China Market Share by Company, 2019-2024
3.2 China Clinical Next Generation Sequencing (NGS) Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Clinical Next Generation Sequencing (NGS) Industry Chain
4.2 Clinical Next Generation Sequencing (NGS) Upstream Analysis
4.2.1 Clinical Next Generation Sequencing (NGS) Core Raw Materials
4.2.2 Main Manufacturers of Clinical Next Generation Sequencing (NGS) Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Clinical Next Generation Sequencing (NGS) Production Mode
4.6 Clinical Next Generation Sequencing (NGS) Procurement Model
4.7 Clinical Next Generation Sequencing (NGS) Industry Sales Model and Sales Channels
4.7.1 Clinical Next Generation Sequencing (NGS) Sales Model
4.7.2 Clinical Next Generation Sequencing (NGS) Typical Distributors
5 Sights by Type5.1 Clinical Next Generation Sequencing (NGS) Classification
5.1.1 Sequencing by Synthesis (SBS)
5.1.2 Nanopore Sequencing
5.1.3 Single-Molecule Real-Time (SMRT) Sequencing
5.1.4 Others5.2 By Type, Global Clinical Next Generation Sequencing (NGS) Consumption Value & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Clinical Next Generation Sequencing (NGS) Consumption Value, 2019-2030
6 Sights by Application6.1 Clinical Next Generation Sequencing (NGS) Segment by Application
6.1.1 Diagnostics
6.1.2 Drug Discovery & Designing
6.1.3 Medical Research
6.1.4 Others6.2 By Application, Global Clinical Next Generation Sequencing (NGS) Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Clinical Next Generation Sequencing (NGS) Consumption Value, 2019-2030
7 Sales Sights by Region7.1 By Region, Global Clinical Next Generation Sequencing (NGS) Consumption Value, 2019 VS 2024 VS 2030
7.2 By Region, Global Clinical Next Generation Sequencing (NGS) Consumption Value, 2019-2030
7.3 North America
7.3.1 North America Clinical Next Generation Sequencing (NGS) & Forecasts, 2019-2030
7.3.2 By Country, North America Clinical Next Generation Sequencing (NGS) Market Size Market Share7.4 Europe
7.4.1 Europe Clinical Next Generation Sequencing (NGS) Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size Market Share7.6 South America
7.6.1 South America Clinical Next Generation Sequencing (NGS) Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Clinical Next Generation Sequencing (NGS) Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Clinical Next Generation Sequencing (NGS) Market Size & CAGR, 2019 VS 2024 VS 2030
8.2 By Country, Global Clinical Next Generation Sequencing (NGS) Consumption Value, 2019-2030
8.3 U.S.
8.3.1 U.S. Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.3.2 By Type, U.S. Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.3.3 By Application, U.S. Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 20308.4 Europe
8.4.1 Europe Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.4.2 By Type, Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.4.3 By Application, Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 20308.5 China
8.5.1 China Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.5.2 By Type, China Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.5.3 By Application, China Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 20308.6 Japan
8.6.1 Japan Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.6.2 By Type, Japan Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.6.3 By Application, Japan Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.7.2 By Type, South Korea Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.7.3 By Application, South Korea Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.8.2 By Type, Southeast Asia Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.8.3 By Application, Southeast Asia Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.9 India
8.9.1 India Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.9.2 By Type, India Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.9.3 By Application, India Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 20308.10 Middle East & Africa
8.10.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size, 2019-2030
8.10.2 By Type, Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
8.10.3 By Application, Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share, 2024 VS 2030
9 Company Profile9.1 Agilent Technologies
9.1.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position
9.1.2 Agilent Technologies Company Profile and Main Business
9.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.1.4 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.1.5 Agilent Technologies Recent Developments9.2 Illumina
9.2.1 Illumina Company Information, Head Office, Market Area and Industry Position
9.2.2 Illumina Company Profile and Main Business
9.2.3 Illumina Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.2.4 Illumina Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.2.5 Illumina Recent Developments9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.3.2 Thermo Fisher Scientific Company Profile and Main Business
9.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.3.5 Thermo Fisher Scientific Recent Developments9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
9.4.2 Eurofins Scientific Company Profile and Main Business
9.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.4.4 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.4.5 Eurofins Scientific Recent Developments9.5 BGI Group
9.5.1 BGI Group Company Information, Head Office, Market Area and Industry Position
9.5.2 BGI Group Company Profile and Main Business
9.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.5.4 BGI Group Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.5.5 BGI Group Recent Developments9.6 Qiagen
9.6.1 Qiagen Company Information, Head Office, Market Area and Industry Position
9.6.2 Qiagen Company Profile and Main Business
9.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.6.4 Qiagen Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.6.5 Qiagen Recent Developments
9.7 Roche Diagnostics
9.7.1 Roche Diagnostics Company Information, Head Office, Market Area and Industry Position
9.7.2 Roche Diagnostics Company Profile and Main Business
9.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.7.4 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.7.5 Roche Diagnostics Recent Developments
9.8 Bio-Rad
9.8.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
9.8.2 Bio-Rad Company Profile and Main Business
9.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.8.4 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.8.5 Bio-Rad Recent Developments
9.9 Congenica
9.9.1 Congenica Company Information, Head Office, Market Area and Industry Position
9.9.2 Congenica Company Profile and Main Business
9.9.3 Congenica Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.9.4 Congenica Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.9.5 Congenica Recent Developments9.10 Theragen Etex
9.10.1 Theragen Etex Company Information, Head Office, Market Area and Industry Position
9.10.2 Theragen Etex Company Profile and Main Business
9.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.10.4 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.10.5 Theragen Etex Recent Developments
9.11 PerkinElmer
9.11.1 PerkinElmer Company Information, Head Office, Market Area and Industry Position
9.11.2 PerkinElmer Company Profile and Main Business
9.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.11.4 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.11.5 PerkinElmer Recent Developments
9.12 Partek
9.12.1 Partek Company Information, Head Office, Market Area and Industry Position
9.12.2 Partek Company Profile and Main Business
9.12.3 Partek Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.12.4 Partek Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.12.5 Partek Recent Developments
9.13 Oxford Nanopore Technologies
9.13.1 Oxford Nanopore Technologies Company Information, Head Office, Market Area and Industry Position
9.13.2 Oxford Nanopore Technologies Company Profile and Main Business
9.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.13.4 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.13.5 Oxford Nanopore Technologies Recent Developments
9.14 Pacific Biosciences of California
9.14.1 Pacific Biosciences of California Company Information, Head Office, Market Area and Industry Position
9.14.2 Pacific Biosciences of California Company Profile and Main Business
9.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.14.4 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.14.5 Pacific Biosciences of California Recent Developments
9.15 Golden Helix
9.15.1 Golden Helix Company Information, Head Office, Market Area and Industry Position
9.15.2 Golden Helix Company Profile and Main Business
9.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.15.4 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.15.5 Golden Helix Recent Developments
9.16 BioDatomics
9.16.1 BioDatomics Company Information, Head Office, Market Area and Industry Position
9.16.2 BioDatomics Company Profile and Main Business
9.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.16.4 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.16.5 BioDatomics Recent Developments
9.17 PierianDx
9.17.1 PierianDx Company Information, Head Office, Market Area and Industry Position
9.17.2 PierianDx Company Profile and Main Business
9.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.17.4 PierianDx Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.17.5 PierianDx Recent Developments
9.18 DNAStar
9.18.1 DNAStar Company Information, Head Office, Market Area and Industry Position
9.18.2 DNAStar Company Profile and Main Business
9.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Models, Specifications and Application
9.18.4 DNAStar Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024
9.18.5 DNAStar Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Clinical Next Generation Sequencing (NGS) Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Clinical Next Generation Sequencing (NGS) Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
According to the report, the Clinical Next Generation Sequencing (NGS) Global and China Top Players Industry will grow to USD XXX Million by 2029, with a YY% CAGR.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Clinical Next Generation Sequencing (NGS) Global and China Top Players Market across the extensive corporate landscape.
The latest version of the Clinical Next Generation Sequencing (NGS) Global and China Top Players Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
